TG Therapeutics Inc
F:NKB2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
TG Therapeutics Inc
F:NKB2
|
US |
|
Daifuku Co Ltd
OTC:DAIUF
|
JP |
Wall St Price Targets
NKB2 Price Targets Summary
TG Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for NKB2 is 36.22 EUR with a low forecast of 10.86 EUR and a high forecast of 46.25 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NKB2's stock price target?
Price Target
36.22
EUR
According to Wall Street analysts, the average 1-year price target for NKB2 is 36.22 EUR with a low forecast of 10.86 EUR and a high forecast of 46.25 EUR.
What is the Revenue forecast for TG Therapeutics Inc?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Revenue has been 122%. The projected CAGR for the next 8 years is 22%.
What is the Gross Profit forecast for TG Therapeutics Inc?
Projected CAGR
23%
The compound annual growth rate for Gross Profit over the next 8 years is 23%.
What is the Operating Income forecast for TG Therapeutics Inc?
Projected CAGR
40%
The compound annual growth rate for Operating Income over the next 8 years is 40%.
What is the Pre-Tax Income forecast for TG Therapeutics Inc?
Projected CAGR
86%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 86%.
What is the Net Income forecast for TG Therapeutics Inc?
Projected CAGR
13%
The compound annual growth rate for Net Income over the next 5 years is 13%.
